Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.

RPEP-026762015RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
Published In:
Diabetes spectrum : a publication of the American Diabetes Association, 28(4), 283-8 (2015)
Database ID:
RPEP-02676

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-02676·https://rethinkpeptides.com/research/RPEP-02676

APA

Jones, S Christopher; Ryan, Debra L; Pratt, Valerie S W; Niak, Ali; Brinker, Allen D. (2015). Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.. Diabetes spectrum : a publication of the American Diabetes Association, 28(4), 283-8. https://doi.org/10.2337/diaspect.28.4.283

MLA

Jones, S Christopher, et al. "Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.." Diabetes spectrum : a publication of the American Diabetes Association, 2015. https://doi.org/10.2337/diaspect.28.4.283

RethinkPeptides

RethinkPeptides Research Database. "Injection-Site Nodules Associated With the Use of Exenatide ..." RPEP-02676. Retrieved from https://rethinkpeptides.com/research/jones-2015-injectionsite-nodules-associated-with

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.